Cristie Columbus

Publications by Year

Research Areas

SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, Influenza Virus Research Studies, Vaccine Coverage and Hesitancy, COVID-19 Clinical Research Studies

Most-Cited Works

• → Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022(2022)115 cited
• → Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023(2023)89 cited
• → Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States(2024)82 cited
• → Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024(2024)73 cited
• → Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults(2024)68 cited
• → Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025(2025)58 cited
• → RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older(2024)53 cited
• → Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023(2023)44 cited
• → Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025(2025)39 cited
• → Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023(2023)33 cited